How do you choose between moderate hypofractionation vs SBRT for intact low or intermediate risk prostate cancer patients?
Are there clinical factors that go into your decision making?
Answer from: Radiation Oncologist at Academic Institution
In low-risk prostate cancer patients, hypofractionated regimens have been proven to be equivalent to standard fractionation in randomized studies (e.g. RTOG 0415 - Lee et al., PMID 27044935). Mulitiple non-randomized studies have shown that SBRT appears to have comparable results to historical contr...
Comments
Radiation Oncologist at Owensboro Health Mitchell Memorial Cancer Center Those above-mentioned criteria are excellent. I ha...
Those above-mentioned criteria are excellent. I ha...